Results 221 to 230 of about 124,603 (293)

Treatment of Migraine With Phytocannabinoids, the Involvement of Endocannabinoids in Migraine, and Potential Mechanisms of Action. [PDF]

Pain Res Manag
Biringer RG.
europepmc   +1 more source

Efficacy and safety of rimegepant for the acute treatment of migraine in Japan: A dose‐ranging, double‐blind, randomized controlled trial

Headache: The Journal of Head and Face Pain, EarlyView.
Plain Language Summary: This randomized trial was designed to test the effectiveness and safety of rimegepant for the acute treatment of migraine among adults in Japan. Results indicated that rimegepant was more effective than placebo, and the 75 mg dose was observed to be more effective than the 25 mg dose.
Koichi Ikeda, Yasuhiko Matsumori, Masako Kudo, Tomofumi Ishikawa, Yuko Hoshino, Hiroki Yoshimatsu, Alexandra Thiry, Akio Arakawa, Robert Croop, Terence Fullerton, Fumihiko Sakai, Takao Takeshima   +11 more
wiley   +1 more source

Impact of Dietary Patterns on Migraine Management: Mechanisms of Action and Recent Literature Insights. [PDF]

Brain Behav
Behrouz V, Hakimi E, Mir E.
europepmc   +1 more source

ON MIGRAINE [PDF]

BMJ, 1908
openaire   +2 more sources

Migraine [PDF]

Postgraduate Medical Journal, 1954
openaire   +2 more sources

Efficacy and safety of rimegepant for the preventive treatment of migraine in Japan: A double‐blind, randomized controlled trial

Headache: The Journal of Head and Face Pain, EarlyView.
Plain Language Summary: This study tested the effectiveness of rimegepant for migraine prevention in Japan. Results showed that rimegepant was more effective than placebo in reducing monthly migraine days, with very few adverse effects. These results support the previous findings from a clinical study conducted in the United States and broaden them to ...
Shigekazu Kitamura, Yasuhiko Matsumori, Toshimasa Yamamoto, Tomofumi Ishikawa, Yuko Hoshino, Hiroki Yoshimatsu, Alexandra Thiry, Akio Arakawa, Robert Croop, Terence Fullerton, Fumihiko Sakai, Takao Takeshima   +11 more
wiley   +1 more source

Oral and Gut Dysbiosis in Migraine: Oral Microbial Signatures as Biomarkers of Migraine. [PDF]

Neurol Neuroimmunol Neuroinflamm
Cho S, Jung Y, Oh HS, Yum J, Song S, Jeong J, Ha WS, Kim KM, Kim WJ, Chu MK.   +9 more
europepmc   +1 more source

Underdiagnosis and impact of menstrual migraine in real‐world clinical practice: A real‐world survey

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective This cross‐sectional study aimed to evaluate the frequency of menstrual migraine (MM) reporting in clinical practice and to compare the clinical burden, treatment patterns, and patient satisfaction between those with and without MM.
Gisela Terwindt, Jessica Ailani, Jessica Cirillo, Lucy Abraham, Aaron Jenkins, Phillip Saccone, Karin Hygge Blakeman, Feng Dai, James Jackson, Sophie Barlow, William Whitton, Lucy Hancock, Boryana Galabova   +12 more
wiley   +1 more source

Efficacy of Low-Dose BoNT-A Acupoint Injections in Managing Headache, Vertigo, and Allodynia in Vestibular Migraine. [PDF]

J Int Adv Otol
Aydemir G, Ardıç FN, Kara CO, Değirmenci E.   +3 more
europepmc   +1 more source

Early nimodipine treatment in reversible cerebral vasoconstriction syndrome: A serial transcranial Doppler study

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objectives/Background Although nimodipine is commonly used to treat reversible cerebral vasoconstriction syndrome (RCVS), its disease‐modifying effects are not yet understood. We prospectively investigated the effect of nimodipine and treatment initiation timing on the prevention of worsened vasoconstriction in patients with angiogram‐proven ...
Soohyun Cho, Minjung Seong, Mi Ji Lee
wiley   +1 more source